Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Aanbevelingen ziektemodulerende MS-behandeling herzien op basis van nieuwste ontwikkelingen
jun 2024